Karsten Damgaard-Iversen joins Mirada Medical
This article was originally published in Clinica
Oncology imaging firm Mirada Medical (Oxford, UK) has made Karsten Damgaard-Iversen non-executive chairman. Mr Damgaard-Iversen has over 30 years' experience in the healthcare imaging industry, and has worked for companies including Toshiba Medical Systems and Fisher Imaging. Currently, he is the founder and director of Dutch firm Disease Control Innovations Medical, which develops new medtech businesses. Disease Control Innovations Medical currently supports breast ultrasound specialist SonoCiné and Imaging Diagnostic Systems, which develops laser imaging devices.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.